Kalaris Therapeutics (NASDAQ:KLRS – Get Free Report) posted its earnings results on Tuesday. Kalaris Therapeutics Price PerformanceNASDAQ:KLRS opened at $3.94 on Tuesday. Kalaris Therapeutics has a one year low of $2.14 and a one year high of $11.88. Get Kalaris Therapeutics alerts:Insider Transactions at Kalaris TherapeuticsIn related news, Director Srinivas Akkaraju purchased 244,300 shares of Kalaris Therapeutics stock in a transaction on Wednesday, May 20th. Further ReadingReceive News & Ratings for Kalaris Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kalaris Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.